Poly-γ-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 215-222

  Scorpio, Angelo ^a   Chabot, Donald J ^a   Day, William A ^a   O'Brien, David K ^a   Vietri, Nicholas J ^a   Itoh, Yoshifumi ^b   Mohamadzadeh, Mansour ^a   Friedlander, Arthur M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA POLYGLUTAMIC ACID DEPOLYMERASE; GAMMA POLYGLUTAMIC ACID HYDROLASE; GLUTAMIC ACID DERIVATIVE; GLUTAMYLASE; POLY GAMMA GLUTAMIC ACID; PROTEIN CAPD; PROTEIN PGHP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTHRAX; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIOPHAGE; CONTROLLED STUDY; ENCAPSULATION; ENZYME DEGRADATION; ENZYME THERAPY; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELLS, CULTURED; GAMMA-GLUTAMYL HYDROLASE; GAMMA-GLUTAMYLTRANSFERASE; MACROPHAGES; MICE; PHAGOCYTOSIS; POLYGLUTAMIC ACID; RECOMBINANT PROTEINS;

EID: 33845994067     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00706-06     Document Type: Article

References (64)

1. Abalakin, V. A., E. G. Sirina, and T. D. Cherkasova. 1990. The effect of lethal anthrax toxin on the functional activity of peritoneal mononuclear phagocytes and polymorphonuclear neutrophils in mice. Zh. Mikrobiol. Epidemiol. Immunobiol. 2:62-67. (In Russian.)
2. Avery, O. T., and R. Dubos. 1931. The protective action of a specific enzyme against type III pneumococcus infection in mice. J. Exp. Med. 54:73-89.
3. Bourgogne, A., M. Drysdale, S. G. Hilsenbeck, S. N. Peterson, and T. M. Koehler. 2003. Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids. Infect. Immun. 71:2736-2743.
4. Candela, T., and A. Fouet. 2005. Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol. Microbiol. 57:717-726.
5. Candela, T., and A. Fouet. 2006. Poly-gamma-glutamate in bacteria. Mol. Microbiol. 60:1091-1098.
6. Chabot, D. J., A. Scorpio, S. A. Tobery, S. F. Little, S. L. Norris, and A. M. Friedlander. 2004. Anthrax capsule vaccine protects against experimental infection. Vaccine 23:43-47.
7. Cote, C. K., K. M. Rea, S. L. Norris, N. van Rooijen, and S. L. Welkos. 2004. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb. Pathog. 37:169-175.
8. Cote, C. K., N. V. Rooijen, and S. L. Welkos. 2006. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immun. 74:469-480.
9. Cromartie, W. J., W. I. Bloom, and D. W. Watson. 1947. Studies on infection with Bacillus anthracis. I. A histological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J. Infect. Dis. 80:1-13.
10. Dixon, T. C., A. A. Fadl, T. M. Koehler, J. A. Swanson, and P. C. Hanna. 2000. Early Bacillus anthracis-macrophage interactions: intracellular survival and escape. Cell. Microbiol. 2:453-463.
11. Drysdale, M., A. Bourgogne, S. G. Hilsenbeck, and T. M. Koehler. 2004. atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB. J. Bacteriol. 186:307-315.
12. Drysdale, M., A. Bourgogne, and T. M. Koehler. 2005. Transcriptional analysis of the Bacillus anthracis capsule regulators. J. Bacteriol. 187:5108-5114.
13. During, R. L., W. Li, B. Hao, J. M. Koenig, D. S. Stephens, C. P. Quinn, and F. S. Southwick. 2005. Anthrax lethal toxin paralyzes neutrophil actin-based motility. J. Infect. Dis. 192:837-845.
14. Reference deleted.
15. Ezzell, J. W., and T. G. Abshire. 1995. Encapsulation of Bacillus anthracis spores and spore identification. Salisbury Med. Bull. Suppl. 87:42.
16. Frank, M. M., and J. P. Atkinson. 2001. Complement system, p. 281-299. In K. D. Austen, M. M. Frank, J. P. Atkinson, and H. Cantor (ed.), Samter's immunologic diseases, 6th ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA.
17. Green, B. D., L. Battisti, T. M. Koehler, C. B. Thorne, and B. E. Ivins. 1985. Demonstration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 49:291-297.
18. Guidi-Rontani, C., M. Levy, H. Ohayon, and M. Mock. 2001. Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol. Microbiol. 42:931-938.
19. Guidi-Rontani, C., M. Weber-Levy, E. Labruyere, and M. Mock. 1999. Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. 31:9-17.
20. Guignot, J., M. Mock, and A. Fouet. 1997. AtxA activates the transcription of genes harbored by both Bacillus anthracis virulence plasmids. FEMS Microbiol. Lett. 147:203-207.
21. Joyce, J., J. Cook, D. Chabot, R. Hepler, W. Shoop, Q. Xu, T. Stambaugh, M. Aste-Amezaga, S. Wang, L. Indrawati, M. Bruner, A. Friedlander, P. Keller, and M. Caulfield. 2006. Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy. J. Biol. Chem. 281:4831-4843.
22. Kang, T. J., M. J. Fenton, M. A. Weiner, S. Hibbs, S. Basu, L. Baillie, and A. S. Cross. 2005. Murine macrophages kill the vegetative form of Bacillus anthracis. Infect. Immun. 73:7495-7501.
23. Keppie, J., P. W. Harris-Smith, and H. Smith. 1963. The chemical basis of the virulence of Bacillus anthracis. IX. Its aggressins and their mode of action. Br. J. Exp. Pathol. 44:446-453.
24. Kimura, K., and Y. Itoh. 2003. Characterization of poly-γ-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillus subtilis encapsulated with poly-γ-glutamate. Appl. Environ. Microbiol. 69:2491-2497.
25. Kocianova, S., C. Vuong, Y. Yao, J. M. Voyich, E. R. Fischer, F. R. DeLeo, and M. Otto. 2005. Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J. Clin. Investig. 115: 688-694.
26. Koehler, T. M. 2002. Bacillus anthracis genetics and virulence gene regulation. Curr. Top. Microbiol. Immunol. 271:143-164.
27. Kozel, T. R., W. J. Murphy, S. Brandt, B. R. Blazar, J. A. Lovchik, P. Thorkildson, A. Percival, and C. R. Lyons. 2004. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl. Acad. Sci. USA 101:5042-5047.
28. 4. J. Immunol. 167:2869-2878.
29. Li, Y., A. Karlin, J. D. Loike, and S. C. Silverstein. 2002. A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc. Natl. Acad. Sci. USA 99:8289-8294.
30. Makino, S.-I., I. Uchida, N. Terakado, C. Sasakawa, and M. Yoshikawa. 1989. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J. Bacteriol. 171: 722-730.
31. Makino, S.-I., M. Watarai, H. I. Cheun, T. Shirahata, and I. Uchida. 2002. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. J. Infect. Dis. 186:227-233.
32. Mayer-Scholl, A., R. Hurwitz, V. Brinkmann, M. Schmid, P. Jungblut, Y. Weinrauch, and A. Zychlinsky. 2005. Human neutrophils kill Bacillus anthracis. PLoS Pathog. 1:179-186.
33. McCloy, E. W. 1951. Studies on a lysogenic Bacillus strain. I. A bacteriophage specific for Bacillus anthracis. J. Hyg. 49:114-125.
34. Metchnikoff, E. 1905. Immunity in infective diseases. Cambridge University Press, Cambridge, United Kingdom.
35. Meynell, E., and G. G. Meynell. 1964. The roles of serum and carbon dioxide in capsule formation by Bacillus anthracis. J. Gen. Microbiol. 34:153-164.
36. Mikesell, P., B. E. Ivins, J. D. Ristroph, and T. M. Dreier. 1983. Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect. Immun. 39: 371-376.
37. Mushtaq, N., M. B. Redpath, J. P. Luzio, and P. W. Taylor. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob. Agents Chemother. 48:1503-1508.
38. Mushtaq, N., M. B. Redpath, J. P. Luzio, and P. W. Taylor. 2005. Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase. J. Antimicrob. Chemother. 24:160-165.
39. O'Brien, D. K., W. J. Ribot, S. A. Tobery, and A. M. Friedlander. 2005. Abstr. Bacillus ACT 2005, abstr. P97.
40. O'Brien, D. K., A. Scorpio, D. Chabot, R. I. Lehrer, and A. M. Friedlander. 2005. Abstr. Bacillus ACT 2005, abstr. P96.
41. O'Brien, J., A. Friedlander, T. Dreier, J. Ezzell, and S. Leppla. 1985. Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47:306-310.
42. Preisz, H. 1909. Experimentelle Studien Åber Virulenz, Empfänglichkeit und Immunität beim Milzbrand. Z. Immun.-Forsch. 5:341-452.
43. Ray, K. C., S. Mesnage, R. Washburn, M. Mock, A. Fouet, and M. J. Blaser. 1998. Abstr. 98th Gen. Meet. Am. Soc. Microbiol., abstr. B-418.
44. Romero-Steiner, R., D. Libutti, L. B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. C. Carbone. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
45. Ross, J. M. 1957. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 73:485-494.
46. Ruthel, G., W. J. Ribot, S. Bavari, and T. A. Hoover. 2004. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J. Infect. Dis. 189:1313-1316.
47. Sahly, H., R. Podschun, T. A. Oelschlaeger, M. Greiwe, H. Parolis, D. Hasty, J. Kekow, U. Ullmann, I. Ofek, and S. Sela. 2000. Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae. Infect. Immun. 68:6744-6749.
48. Schembri, M. A., D. Dalsgaard, and P. Klemm. 2004. Capsule shields the function of short bacterial adhesins. J. Bacteriol. 186:1249-1257.
49. Schneerson, R., J. Kubler-Kielb, T. Y. Liu, Z. D. Dai, S. H. Leppla, A. Yergey, P. Backlund, J. Shiloach, F. Majadly, and J. B. Robbins. 2003. Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc. Natl. Acad. Sci. USA 100:8945-8950.
50. Shafa, F., B. J. Moberly, and P. Gerhardt. 1966. Cytological features of anthrax spores phagocytized in vitro by rabbit alveolar macrophages. J. Infect. Dis. 116:401-413.
51. Shlyakhov, E. N., and E. Rubinstein. 1994. Human live anthrax vaccine in the former USSR. Vaccine 12:727-730.
52. Smith, H., J. Keppie, and J. L. Stanley. 1953. The chemical basis of the virulence of Bacillus anthracis. I. Properties of bacteria grown in vivo and preparation of extracts. Br. J. Exp. Pathol. 34:477-485.
53. Reference deleted.
54. Turnbull, P. C. 1991. Anthrax vaccines: past, present and future. Vaccine 9:533-539.
55. Uchida, I., S. Makino, C. Sasakawa, M. Yoshikawa, C. Sugimoto, and N. Terakado. 1993. Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis. Mol. Microbiol. 9:487-496.
56. Uchida, I., S. Makino, T. Sekizaki, and N. Terakado. 1997. Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis. Mol. Microbiol. 23:1229-1240.
57. Uchida, I., T. Sekizaki, K. Hashimoto, and N. Terakado. 1985. Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. J. Gen. Microbiol. 131:363-367.
58. Utsumi, S., M. Torii, H. Yamamuro, O. Kurimura, and T. Amano. 1961. Gamma-glutamylase as a decapsulating agent for Bacillus anthracis. Biken J. 4:151-169.
59. Vaudremer, A. 1927. Les bacille tuberculeux. Les Universitaires de France, Paris, France.
60. Vietri, N. J., R. Marrero, T. A. Hoover, and S. L. Welkos. 1995. Identification and characterization of a trans-activator involved in the regulation of encapsulation by Bacillus anthracis. Gene 152:1-9.
61. Virji, M., K. Makepeace, I. R. Peak, D. J. Ferguson, M. P. Jennings, and E. R. Moxon. 1995. Ope- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol. Microbiol. 18:741-754.
62. Wang, T. T., P. F. Fellows, T. J. Leighton, and A. H. Lucas. 2004. Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate. FEMS Immunol. Med. Microbiol. 40:231-237.
63. Welkos, S., A. Friedlander, S. Weeks, S. Little, and I. Mendelson. 2002. In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J. Med. Microbiol. 51:821-831.
64. Wright, G. G., P. W. Read, and G. L. Mandell. 1988. Lipopolysaccharide releases a priming substance from platelets that augments the oxidative response of polymorphonuclear neutrophils to chemotactic peptide. J. Infect. Dis. 157:690-696.